Key result
Dobutamine echocardiography is discussed as a valuable technique for assessing myocardial viability and selecting patients with coronary artery disease for revascularization.
Why the study?
Does dobutamine echocardiography accurately assess myocardial viability for revascularization in patients with severe left ventricular dysfunction and coronary artery disease?
Does dobutamine echocardiography accurately assess myocardial viability for revascularization in patients with severe left ventricular dysfunction and coronary artery disease?
Dobutamine echocardiography is highlighted as a useful technique for assessing myocardial viability to guide revascularization in patients with severe left ventricular dysfunction.
Viability assessment with dobutamine echocardiography may inform CAD revascularization in heart failure; leaves open need for randomized confirmation.
Coronary artery disease accounts for a majority of heart failure cases in the western world. Many cardiologists believe that abnormal regional contractions in patients with coronary artery disease is equivalent to irreversibly damaged myocardium. Studies now challenge this long-held assumption. Data exist regarding the value of assessing myocardial viability in those patients with severe left ventricular dysfunction and coronary artery disease. This report discusses dobutamine echocardiography as a technique for assessing myocardial viability and for selecting patients for revascularization.
No takes yet. Share an insight, caveat, or question.
Senior et al. (2001) conducted a review in Coronary artery disease with severe left ventricular dysfunction. Dobutamine echocardiography was evaluated. Dobutamine echocardiography is discussed as a valuable technique for assessing myocardial viability and selecting patients with coronary artery disease for revascularization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: